Evidence map›Paper›PMID 38019076›Full record

ArticleCancer research communications2023

Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 Mutation.

Emma Guyonnet, Shana J Kim, Yue Yin Xia, Vasily Giannakeas, Jan Lubinski, Susan Randall Armel, Andrea Eisen, Louise Bordeleau, Charis Eng, Olufunmilayo I Olopade and 6 more

Open access · goldAbstract read
In one paragraph

Article in Cancer research communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 0 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 3 countries.

Emma GuyonnetWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.ORCID 0000-0002-9038-1972
Shana J KimWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.ORCID 0009-0008-8816-5518
Yue Yin XiaDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0003-2442-2729
Vasily GiannakeasWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.ORCID 0000-0003-2924-8723
Jan LubinskiInternational Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.ORCID 0000-0003-2931-3003
Susan Randall ArmelBhalwani Familial Cancer Clinic, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.ORCID 0000-0001-5016-3148
Andrea EisenToronto-Sunnybrook Regional Cancer Center, Toronto, Canada.ORCID 0000-0001-8037-9556
Louise BordeleauDepartment of Oncology, Juravinski Cancer Centre, Hamilton, Canada.ORCID 0000-0003-2111-0228
Charis EngGenomic Medicine Institute, Center for Personalised Genetic Healthcare, Cleveland Clinic, Cleveland, Ohio.ORCID 0000-0002-3693-5145
Olufunmilayo I OlopadeDepartment of Medicine and Human Genetics, University of Chicago, Chicago, Illinois.ORCID 0000-0002-9936-1599
Nadine TungBeth Israel Deaconess Medical Center, Boston, Massachusetts.ORCID 0000-0003-1422-3734
William D FoulkesProgram in Cancer Genetics, Department of Oncology and Human Genetics, McGill University, Montréal, Quebec, Canada.ORCID 0000-0001-7427-4651
Fergus J CouchDivision of Experimental Pathology and Laboratory Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-9417-9985
Amber M AeiltsDivision of Human Genetics, Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, Ohio.ORCID 0000-0001-8907-7853
Steven A NarodWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.ORCID 0000-0001-5798-0626
Joanne KotsopoulosWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.ORCID 0000-0001-9624-4218
University of Toronto · CACancer Genetics (United States) · USBeth Israel Deaconess Medical Center · USCleveland Clinic · USInternational Hereditary Cancer Center · PLJuravinski Cancer Centre · CAMayo Clinic · USSunnybrook Health Science Centre · CAUniversity of Illinois Chicago · US

Funding

CCS | Canadian Cancer Society Research Institute (CCSRI) 703058CIHR Canada Graduate Scholarships Doctoral AwardPeter Gilgan Foundation (The Peter Gilgan Foundation)Sondra J and Stephen R Hardis Endowed Chair of Cancer Genomic MedicineTier I Canada Research ChairTier II Canada Research Chair
6 · The paper itself

Abstract

In the general population, physical activity has been associated with a lower risk of several cancers; however, the evidence for ovarian cancer is not clear. It is suggested that early-life physical activity may differentially impact risk. Whether this is true among women at high risk due to a pathogenic variant (mutation) in the BRCA1 or BRCA2 genes has not been evaluated. Thus, we performed a matched case-control study to evaluate the association between adolescent and early-adulthood physical activity and ovarian cancer. BRCA mutation carriers who completed a research questionnaire on various exposures and incident disease and with data available on physical activity were eligible for inclusion. Self-reported activity at ages 12-13, 14-17, 18-22, 23-29, and 30-34 was used to calculate the average metabolic equivalent of task (MET)-hours/week for moderate, vigorous, and total physical activity during adolescence (ages 12-17) and early-adulthood (ages 18-34). Conditional logistic regression was used to estimate the OR and 95% confidence intervals (CI) of invasive ovarian cancer associated with physical activity. This study included 215 matched pairs (mean age = 57.3). There was no association between total physical activity during adolescence (ORhigh vs. low = 0.91; 95% CI: 0.61-1.36; Ptrend = 0.85), early-adulthood (ORhigh vs. low = 0.78; 95% CI: 0.51-1.20; Ptrend = 0.38) and overall (ORhigh vs. low = 0.81; 95% CI: 0.54-1.23; Ptrend = 0.56) and ovarian cancer. Findings were similar for moderate (Ptrend ≥ 0.25) and vigorous (Ptrend ≥ 0.57) activity. These findings do not provide evidence for an association between early-life physical activity and BRCA-ovarian cancer; however, physical activity should continue to be encouraged to promote overall health. SIGNIFICANCE: In this matched case-control study, we observed no association between physical activity during adolescence or early-adulthood and subsequent risk of ovarian cancer. These findings do not provide evidence for an association between early-life physical activity and BRCA-ovarian cancer; however, being active remains important to promote overall health and well-being.

Indexed as

Ovarian NeoplasmsAdolescentAdultBRCA1 ProteinBRCA2 ProteinCase-Control StudiesExerciseFemaleGenes, BRCA2HumansMiddle AgedMutationBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human

Identifiers

PMID38019076
PMCPMC10683556
OpenAlexW4389085040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.